0 CHECKOUT

Global Proteomics Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 - 2022

  • ID: 3460517
  • March 2016
  • Region: Global
  • 140 Pages
  • Occams Business Research and Consulting
1 of 4
The Global Proteomics Market Is Expected To Grow At a CAGR Of 20% For the Forecasted Period Of 2015-2021

FEATURED COMPANIES

  • Activx Biosciences Inc
  • Anaspec Inc
  • Beckman coulter
  • Biocarta Inc
  • Cellzome AG
  • Dualsystems biotech AG
  • MORE

The proteomics market is segmented on the basis of proteomics instrumentation technology such as protein micro array (biochips, micro array instruments), spectroscopy (Mass and NMR), X-ray crystallography, chromatography, electrophoresis, proteomics reagents, proteomics services (analytical lab services, protein identification, extraction, sequencing, data analysis, maintaining bioinformatics data bases). The market is driven by growing need of personalized medicines, new discoveries in the field of genomics, rise in funds for proteomics based research, growing research and development expenditure, advancement in technologies, new techniques, high output, high resolutions achiness and instruments have been developed, availability of private funds and rise in the Asian markets like China and Japan. The top 10 companies own 40 to 50 percent of the market.

Proteomic instrumentation market is dominated by proteomic microarray, accounting for around 50% of the revenue followed by spectroscopy techniques. Proteomic reagents market is dominated by immunoassays.
The market is restrained by various factors such as: success ratio of the researches is not very high, limitations of READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Activx Biosciences Inc
  • Anaspec Inc
  • Beckman coulter
  • Biocarta Inc
  • Cellzome AG
  • Dualsystems biotech AG
  • MORE

1. Introduction
1.1. Executive summary
1.2. Estimation methodology
2. Market overview
2.1. Market definition and scope
2.2. Key findings
2.3. Parametric analysis
2.3.1. Global proteomic R&D expenditure
2.3.2. Global personalized medicine market
2.3.3. Global drug discovery programs
2.3.4. Healthcare expenditure across geographies
2.3.5. Disposable income of top emerging economies
2.4. Key market insights
2.4.1. Top 3 emerging countries
2.4.2. Top 3 revenue generating segments
2.4.3. Top growing markets and emerging trends
2.4.4. R&D scenario in proteomics market
2.4.5. Pricing analysis
2.5. Competitive intelligence
2.5.1. Market share analysis
2.5.2. Top winning strategies
2.5.3. Case studies: Top competitive moves
2.6. Value Chain analysis
2.7. Key buying criteria
2.8. Strategic recommendation
2.9. Strategic conclusions
3. Market determinants
3.1. Market drivers
3.1.1. Increased funding by government and private firms in research and development
3.1.2. Increased demand for personalized medicine
3.1.3. High elderly population and prevalence of lifestyle diseases
3.1.4. Technology advancements
3.1.5. Increased understanding of human genome
3.2. Market Restraints
3.2.1. The success ratio of the researches is not very high
3.2.2. Number of non responders is very high
3.2.3. Reduction in funds by the US government, which owes 40% of this market
3.2.4. Highly expensive medicines, which are 1000 fold costlier than the normal medicines present in the market and research
3.2.5. Market is limited to a few developed nations only.
3.3. Market challenges
3.3.1. High price
3.3.2. Weak research and development in emerging markets
3.4. Market opportunities
3.4.1. Development in drug discovery and nanotechnolgy
3.4.2. Markets in emerging geographies
4. Sector Analysis
4.1. Parent market
4.2. Sub-segment market
4.3. Alternative market
5. Market Segmentation
5.1. Global proteomics market, by technology, 2014-2021, ($millions)
5.1.1. Global protein microarray in proteomics market, 2014-2021, ($millions)
5.1.1.1. Global biochips in proteomics market, 2014-2021, ($millions)
5.1.1.2. Global microarray instruments proteomics market, 2014-2021, ($millions)
5.1.1.3. Global spectroscopy in proteomics market, 2014-2021, ($millions)
5.1.1.4. Global X-ray crystallography in proteomics market, 2014-2021, ($millions)
5.1.1.5. Global chromatography in proteomics market, 2014-2021, ($millions)
5.1.1.6. Global chromatography in proteomics market, 2014-2021, ($millions)
5.1.1.7. Global surface plasmon resonance in proteomics market, 2014-2021, ($millions)
5.1.1.8. Global protein fractionation in proteomics market, 2014-2021, ($millions)
5.1.2. Global proteomics reagents market, 2014-2021, ($millions)
5.1.2.1. Global microarray reagents market, 2014-2021, ($millions)
5.1.2.2. Global X-ray crystallography reagents market, 2014-2021, ($millions)
5.1.2.3. Global spectroscopy reagents market, 2014-2021, ($millions)
5.1.2.4. Global immunoassay reagents market, 2014-2021, ($millions)
5.1.2.5. Global chromatography reagents market, 2014-2021, ($millions)
5.1.2.6. Global electrophoresis reagents market, 2014-2021, ($millions)
5.1.2.7. Global protein fractionation reagents market, 2014-2021, ($millions)
5.2. Global proteomics services market, 2014-2021
5.2.1. Global analytical lab services market, 2014-2021, ($millions)
5.2.1.1. Global protein identification market, 2014-2021, ($millions)
5.2.1.2. Global protein extraction market , 2014-2021, ($millions)
5.2.1.3. Global protein sequencing market, 2014-2021, ($millions)
5.2.2. Global data analysis and maintenance market, 2014-2021, ($millions)
5.2.2.1. Global bioinformatics database market, 2014-2021, ($millions)
5.2.2.2. Global bioinformatics tools market, 2014-2021, ($millions)
5.3. Global proteomics market by applications, 2014-2021, ($millions)
5.3.1. Global proteomics in drug discovery market, 2014-2021, ($millions)
5.3.1.1. Neuro-medicine
5.3.1.2. Maternal
5.3.1.3. Cancer
5.3.1.4. Antibody
5.3.1.5. Cardiovascular
5.3.1.6. Diabetes
5.3.1.7. Nutrition
5.3.1.8. Others
5.3.2. Global proteomics in clinical diagnosis market, 2014-2021, ($millions)
6. Competitive Landscape
6.1. Market share
6.2. Strategy – An analysis across tiers
7. Geographical analysis
7.1. North America Proteomic market, 2014-2021, ($millions)
7.2. United States (U.S.) Proteomic market, 2014-2021, ($millions)
7.3. Canada Proteomic market, 2014-2021, ($millions)
7.4. Europe Proteomic market, 2014-2021, ($millions)
7.4.1. United Kingdom (UK) Proteomic market, 2014-2021, ($millions)
7.4.2. France Proteomic market, 2014-2021, ($millions)
7.4.3. Germany Proteomic market, 2014-2021, ($millions)
7.4.4. Spain Proteomic market, 2014-2021, ($millions)
7.4.5. Italy Proteomic market, 2014-2021, ($millions)
7.4.6. RoE Proteomic market, 2014-2021, ($millions)
7.5. Asia Pacific Proteomic market, 2014-2021, ($millions)
7.5.1. India Proteomic market, 2014-2021, ($millions)
7.5.2. China Proteomic market, 2014-2021, ($millions)
7.5.3. Japan Proteomic market, 2014-2021, ($millions)
7.5.4. Korea Proteomic market, 2014-2021, ($millions)
7.5.5. Australia Proteomic market, 2014-2021, ($millions)
7.5.6. RoAPAC Proteomic market, 2014-2021, ($millions)
7.6. Rest of the world Proteomic market, 2014-2021, ($millions)
7.6.1. Latin America Proteomic market, 2014-2021, ($millions)
7.6.2. MENA Proteomic market, 2014-2021, ($millions)
7.6.3. Africa Proteomic market, 2014-2021, ($millions)
8. Company Profiles:
8.1. Genzyme Corporation
8.2. Thermo Fischer scientific corporation
8.3. Becton Dickinson and Co.
8.4. BG medicine
8.5. Agilent technologies
8.6. Luminex corporation
8.7. Sigma-Aldrich corporation
8.8. Danaher corporation
8.9. Anaspec Inc
8.10. Asterand PLC
8.11. Applied biosystems Inc.
8.12. Bayer technology
8.13. Bio-Rad corporation
8.14. Waters corporation
8.15. PerkinElmer
8.16. Affymetrix
8.17. GE healthcare
8.18. Genesystems Inc.
8.19. Activx Biosciences Inc.
8.20. Amgen Inc
8.21. Beckman coulter
8.22. Biacore International AB
8.23. Biocarta Inc
8.24. Bruker biosciences
8.25. Caliper Lifesciences
8.26. Cellzome AG
8.27. Commonwealth biotechnologies
8.28. Digilab biovision GmBH
8.29. Dionex Corp.
8.30. Dualsystems biotech AG

Note: Product cover images may vary from those shown
3 of 4

Genzyme Corporation
Thermo Fischer scientific corporation
Becton Dickinson and Co
BG medicine
Agilent technologies
Luminex corporation
Sigma-Aldrich corporation
Danaher corporation
Anaspec Inc
Asterand PLC
Applied biosystems Inc
Bayer technology
Bio-Rad corporation
Waters corporation
PerkinElmer
Affymetrix
GE healthcare
Genesystems Inc
Activx Biosciences Inc
Amgen Inc
Beckman coulter
Biacore International AB
Biocarta Inc
Bruker biosciences
Caliper Lifesciences
Cellzome AG
Commonwealth biotechnologies
Digilab biovision GmBH
Dionex Corp
Dualsystems biotech AG

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Cache

Our Clients

  • Affymetrix, Inc.
  • Ipsen Group
  • University of Pittsburgh
  • QFAB Bioinformatics
  • Nanostring Technologies, Inc.
  • RTI International